Positive, company-specific developments have given rise to shares Transmedics group ,TMDX 1.08%, And Fubotv ,Fobo 2.17%, This year more than doubled, even as S&P 500 It is barely green since January. Investment knowledge recommends us to buy less, and some people may imagine that after more than 100% return in six months, it is too late to get into these shares. However, Transmedics Group and Fubotv still have excellent possibilities that can be better than longer-average returns.

1. Transmedics group

Transmedics Group, a medical equipment specialist who developed an innovative method to store organs for transplantation, entered the year to face challenges. First, the company’s guidance disappointed investors. Second, was the subject of transmedics Short seller The report of the Scorpion Capital, which created a series of serious allegations, included claims that transmedics group are engaged in organ trafficking.

However, the company has performed well this year due to better performing financial results this year. In the first quarter, the revenue of transmedics increased by 48% year -on -year. Compared to the year-old period, the company’s net earnings came at $ 0.70 per share. To close all this, Transmedics increased its guidance for full financial year 2025.

With such results, even the short-seller report that sinks the price of its share, now looks like a distant memory. The best thing is that there is still quite the opposite capacity for the transmedics group. The company’s organ care system (OCS) technology aims to mimic the physiology of the human body, which enables the storage of the organs for a long time, resulting in a much higher use rate than traditional cold storage methods.

It is difficult to find already available transplants. It is a matter of shame if they become useless due to poor storage. Thus, the transmedics group is helping to bring revolution in organ donation business for its OCS, and is very much space for development. The company estimates that organ donation will grow at a decent rate in the next few years, at least.

Capturing a large portion of the market and improving the rates used for existing organ donations – even if there are not more donors over time – should lead to strong financial results for transmedics group. This is why the stock remains a purchase today, at least for investors already doubled this year, the course is ready to remain for a while.

2. Fabotav

In January, Streaming specialist FUBOTV announced that it was merged Disney‘Hulu+ Live TV. The deal makes Fubotv far more attractive than before for several reasons. First of all, it helps to diversify the company’s offerings. Fubotv was known on sports streaming for its laser focus, which is a niche of the market that can be something seasonal.

Second, the deal came up with the cancellation of Venu Pahal. Disney, foxAnd Warner Brothers discovery A competitive sports-focused streaming platform called Venu was planned to launch the FUBOTV completely killed, given the company’s membership growth rate.

Third, Fubotv received a good infusion of cash as part of the deal. It received $ 220 million from Venu’s former Backers. And it tops the $ 145 million term loan from Disney.

Last but at least, Disney is now Fubotv’s majority shareholder. The support of a long successful media legend with equally successful undertakings in streaming niche will help massively for FUBOTV. Yes, the stock has already touched the sky this year, but given the long -term opportunity in streaming, it should still be very reverse for Fubotv. Crossing the joint part of the broadcast and cable for the first time, there was a streaming of 44.8% of the time of watching television in May in the US.

Nevertheless, it is in America, one of the more penetrating markets. And here too, the possibility of streaming is not at its peak. It indicates a large -scale WhatsApp worldwide. The FUBOTV will have to deal with strict competition, but after merging with Hulu+ Live TV, the company’s new position – and Disney’s support – should do amazing work for a long time. So the stock is still a purchase.